@Article{Wlaźlak2004,
journal="Menopause Review/Przegląd Menopauzalny",
issn="1643-8876",
volume="3",
number="5",
year="2004",
title="Estradiol  - novelty or standard in vaginal therapy?",
abstract="Authors present review of articles about the use of vaginal tablets containing 25 \µg of 17\β-estradiol in the treatment of urogynecological complaints resulting from estrogen deficiency in peri- and postmenopausal women. Data shows that dose of 25 \µg of 17\β-estradiol does not have clinically significant systemic activity. Till now, if properly used, vaginal tablet containing 25 \µg of 17\β-estradiol does not show stimulating activity on endometrium. Authors consider that medicaments containing estradiol ad estriol are both standards in modern vaginal estrogen therapy. Vaginal tablet containing 17\β-estradiol are noticed by most of the patients as more comfortable ad hygienic than vagitories and creams.",
author="Wlaźlak, Edyta
and Surkont, Grzegorz
and Suzin, Jacek",
pages="50--56",
url="https://www.termedia.pl/Estradiol-novelty-or-standard-in-vaginal-therapy-,4,2640,1,1.html"
}